Stock 2696 SHANGHAI HENLIUS BIOTECH, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Transcripts Shanghai Henlius Biotech, Inc.

Equities

2696

CNE100003N76

Delayed Hong Kong S.E.
Other stock markets
 09:21:05 2024-05-15 pm EDT 		5-day change 1st Jan Change
17.58 HKD 0.00% Intraday chart for Shanghai Henlius Biotech, Inc. +0.57% +26.47%
May. 14 Shanghai Henlius Biotech Gets Go-Ahead for Clinical Trials of Breast Cancer Drug in China MT
May. 14 Shanghai Henlius Biotech, Inc. Announces Approval of Application for Clinical Trials of HLX78 (lasofoxifene) by the National Medical Products Administration CI

Transcripts

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 2696 Stock
  4. News Shanghai Henlius Biotech, Inc.
  5. Transcripts
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW